Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro
, , , und
12. Juni 2023
Über diesen Artikel
Online veröffentlicht: 12. Juni 2023
Seitenbereich: 269 - 280
Akzeptiert: 03. Dez. 2022
DOI: https://doi.org/10.2478/acph-2023-0015
Schlüsselwörter
© 2023 Rui Liu et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Liu, Rui
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Jiang, Cuihong
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Zhao, Zhizheng
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Lv, Yutong
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Wang, Gaoxing
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China